RXST
RxSight Inc

455
Mkt Cap
$265.76M
Volume
1.08M
52W High
$27.13
52W Low
$6.32
PE Ratio
-6.76
RXST Fundamentals
Price
$6.44
Prev Close
$6.74
Open
$6.78
50D MA
$8.44
Beta
1.61
Avg. Volume
1.04M
EPS (Annual)
-$0.9533
P/B
0.96
Rev/Employee
$291,711.50
$208.58
Loading...
Loading...
News
all
press releases
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of "Reduce" by Analysts
RxSight, Inc. (NASDAQ:RXST - Get Free Report) has received a consensus recommendation of "Reduce" from the fifteen analysts that are covering the stock, Marketbeat reports. Three equities research...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Meridiem Capital Partners LP Buys New Position in RxSight, Inc. $RXST
Meridiem Capital Partners LP bought a new stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·9d ago
News Placeholder
Stifel Nicolaus Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price
Stifel Nicolaus decreased their price objective on shares of RxSight from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Monday...
MarketBeat·13d ago
News Placeholder
Short Interest in RxSight, Inc. (NASDAQ:RXST) Expands By 29.3%
RxSight, Inc. (NASDAQ:RXST - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 13th, there was short interest totaling 5,358,739...
MarketBeat·19d ago
News Placeholder
Artisan Partners Limited Partnership Cuts Position in RxSight, Inc. $RXST
Artisan Partners Limited Partnership decreased its position in RxSight, Inc. (NASDAQ:RXST - Free Report) by 22.1% during the third quarter, according to the company in its most recent filing with the...
MarketBeat·21d ago
News Placeholder
RxSight (NASDAQ:RXST) Given New $9.00 Price Target at UBS Group
UBS Group raised their price objective on shares of RxSight from $8.00 to $9.00 and gave the company a "neutral" rating in a research note on Thursday...
MarketBeat·24d ago
News Placeholder
RxSight (NASDAQ:RXST) Price Target Lowered to $10.00 at Piper Sandler
Piper Sandler dropped their price objective on RxSight from $11.00 to $10.00 and set a "neutral" rating on the stock in a report on Thursday...
MarketBeat·24d ago
News Placeholder
RxSight Q4 Earnings Call Highlights
RxSight (NASDAQ:RXST) reported fourth-quarter 2025 revenue of $32.6 million, down 19% year-over-year, driven primarily by lower Light Delivery Device (LDD) sales following an unusually strong...
MarketBeat·24d ago
News Placeholder
RxSight (NASDAQ:RXST) Issues Earnings Results
RxSight (NASDAQ:RXST - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by...
MarketBeat·25d ago
News Placeholder
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates
RxSight (RXST) delivered earnings and revenue surprises of +87.14% and +0.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·25d ago
<
1
2
...
>

Latest RXST News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.